Moreover, tissue (Supplementary Figure S6(B)) and cellular (Supplementary Figure S6(C)) distribution analyses demonstrated that the Ze affibody accumulated in HT29 tumor xenografts through binding to EGFR-expressing tumor cells, indicating that the Ze affibody could be used as a carrier for tumor cell-targeted delivery of PS. The gene discussed is EGFR; the disease is neoplasm.